Latest & greatest articles for hepatitis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hepatitis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hepatitis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hepatitis

1. Hepatitis C Virus Infection in Adolescents and Adults: Screening

Hepatitis C Virus Infection in Adolescents and Adults: Screening Recommendation | United States Preventive Services Taskforce Toggle navigation Main navigation Main navigation Recommendation Adults aged 18 to 79 years The USPSTF recommends screening for hepatitis C virus (HCV) infection in adults aged 18 to 79 years. B View the Clinical Summary in What does the USPSTF recommend? For adults aged 18 to 79 years: Grade B Screen adults for hepatitis C virus (HCV) infection. To whom does (...) evidence to determine how often to screen persons at increased risk. What are other relevant USPSTF recommendations? The USPSTF has made recommendations on screening for hepatitis B virus infection in pregnant persons, hepatitis B virus infection in adults, and HIV infection. These recommendations are available at . Where to read the full recommendation statement? Visit the USPSTF website to read the full recommendation statement. This includes more details on the rationale of the recommendation

2020 U.S. Preventive Services Task Force

2. Hepatitis E: symptoms, transmission, prevention, treatment

Hepatitis E: symptoms, transmission, prevention, treatment Hepatitis E: symptoms, transmission, prevention, treatment - GOV.UK GOV.UK uses cookies to make the site simpler. Accept cookies You’ve accepted all cookies. You can at any time. Hide Search Guidance Hepatitis E: symptoms, transmission, prevention, treatment The symptoms, means of transmission, best means of prevention and treatment of hepatitis E. Published 1 June 2014 Last updated 16 July 2019 — From: Documents HTML Details (...) This document explains hepatitis E, describing the: symptoms means of transmission best means of prevention and treatment Published 1 June 2014 Last updated 16 July 2019 16 July 2019 Added provisional data for January to March 2019. 8 March 2019 Updated the number of hepatitis E cases in 2017 and 2018. 7 November 2018 Added provisional data for January to September 2018. 10 August 2018 Added provisional data for January to June 2018. 1 August 2018 Updated 2017 figures. 1 February 2018 Updated number

2020 Public Health England

3. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis. (Abstract)

Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis. Previous study has shown a positive relationship between the hepatitis B virus (HBV) or hepatitis C virus (HCV) infection and cholangiocarcinoma (CCA); however, their correlation with different anatomical sites of CCA (i.e. ICC and ECC) has not been revealed. This study aims to evaluate the association of HBV or HCV infection with CCA

2020 The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

4. Magnitude of and Prediction for Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Taking Entecavir or Tenofovir Therapy: A Systematic Review. (Abstract)

Magnitude of and Prediction for Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Taking Entecavir or Tenofovir Therapy: A Systematic Review. Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) have been shown to reduce incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). This systematic review aims to evaluate the magnitude, change over time, and prediction of residual HCC risks in CHB patients treated with ETV/TDF therapy.Available (...) , cirrhosis (fibrosis grade) and hepatic function. Conflicting results were reported in 7 individual studies and 2 meta-analyses that compared ETV vs. TDF.The residual risk of HCC remains during ETV/TDF treatment in CHB patients with cirrhosis, but declines over time. Risk stratification is attainable by validated predictive scores.This article is protected by copyright. All rights reserved.

2020 Journal of gastroenterology and hepatology

5. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. (Full text)

The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. There are uncertainties about the epidemic patterns of hepatitis delta virus (HDV) infection and its contribution to the burden of liver disease. We estimated the global prevalence of HDV infection and explored its contribution to the development of cirrhosis and hepatocellular carcinoma (HCC) among hepatitis B surface antigen (HBsAg)-positive people.We searched Pubmed, EMBASE and Scopus for studies (...) , and those with hepatitis C virus or HIV. Among HBsAg-positive people, preliminary PAF estimates of HDV were 18% (10, 26) for cirrhosis and 20% (8, 33) for HCC.An estimated 12 million people worldwide have experienced HDV infection, with higher prevalence in certain geographic areas and populations. HDV is a significant contributor to HBV-associated liver disease. More quality data are needed to improve the precisions of burden estimates.Copyright © 2020. Published by Elsevier B.V.

2020 Journal of Hepatology PubMed abstract

6. Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients. (Abstract)

Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients. The prevalence of co-infection of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) is high and increases risk of hepatitis B chronicity and mortality. Despite guidelines for HIV-infected patients to be immunized against HBV, the immunogenicity of the HBV vaccination in HIV-infected patients is lower than that in the HIV-seronegative population.In this study (...) , we performed a systematic review of the literature and meta-analysis of randomized clinical trials to investigate the response rate to an increased dose of HBV vaccination in HIV-infected patients. A fixed-effects model, with heterogeneity and sensitivity analyses, was used. We identified nine studies involving 970 HIV-positive vaccine recipients.The study results were divided into two groups, depending on the time when antibody against hepatitis surface antigen was measured. Results showed

2020 Vaccine

7. Seroprevalence of hepatitis E virus infection in pregnant women: a systematic review and meta-analysis. (Full text)

Seroprevalence of hepatitis E virus infection in pregnant women: a systematic review and meta-analysis. Hepatitis E virus (HEV) infection has emerged as a global public health problem that affects millions of people every year.Systematically review data on the prevalence of HEV IgG antibody among pregnant women around the world.Potentially relevant studies were identified by a search of PubMed and ScienceDirect, and by a manual search of the reference lists of identified studies.Observational

2020 Annals of Saudi Medicine PubMed abstract

8. Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis. (Full text)

Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis. Studies have shown that nucleos(t)ide analogue (NA) treatment can reduce the risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients, but it is unclear which NA is most effective. We performed a meta-analysis and systematic review comparing the efficacies of NAs in CHB patients.We searched literature databases for randomized controlled trials (...) (RCTs) and observational studies that analyzed the hepatic biochemical response, virological response, seroconversion rate, drug resistance rate, and HCC incidence rate in CHB patients treated with NAs. Meta-analyses were performed with RevMan and Stata/SE software.Twelve cohort studies and one RCT were selected, in which entecavir (ETV), lamivudine (LAM), telbivudine (LdT), and/or tenofovir disoproxil fumarate (TDF) were evaluated in CHB patients. The meta-analysis showed that ETV was superior

2020 Gut and liver PubMed abstract

9. The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis. (Full text)

The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis. Hepatitis E virus (HEV), as an emerging zoonotic pathogen, is a leading cause of acute viral hepatitis worldwide, with a high risk of developing chronic infection in immunocompromised patients. However, the global epidemiology of HEV infection has not been comprehensively assessed. This study aims to map the global prevalence and identify the risk factors of HEV infection by performing a systematic

2020 Liver international : official journal of the International Association for the Study of the Liver PubMed abstract

10. Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis. (Abstract)

Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis. Objectives: Chronic hepatitis B (CHB) is a major global health problem caused by hepatitis B virus (HBV) infection, and can put patients at high risk of death from cirrhosis and liver cancer. However, CHB can be treated with nucleos(t)ide analogues. We aimed to evaluate the effectiveness and safety of nucleos(t)ide analogues for the treatment of CHB patients.Methods: A systematic

2020 Expert review of anti-infective therapy

11. Systematic review of liver directed therapy for uveal melanoma hepatic metastases. (Abstract)

Systematic review of liver directed therapy for uveal melanoma hepatic metastases. Uveal melanoma (UM) is a rare malignancy with a propensity for metastasis to the liver. Systemic chemotherapy is typically ineffective in these patients with liver metastases and overall survival is poor. There are no evidence-based guidelines for management of UM liver metastases. The aim of this study was to review the evidence for management of UM liver metastases.A systematic review of English literature (...) publications was conducted across Ovid Medline, Ovid MEDLINE and Cochrane CENTRAL databases until April 2019. The primary outcome was overall survival, with disease free survival as a secondary outcome.55 studies were included in the study, with 2446 patients treated overall. The majority of these studies were retrospective, with 17 of 55 including comparative data. Treatment modalities included surgery, isolated hepatic perfusion (IHP), hepatic artery infusion (HAI), transarterial chemoembolization (TACE

2020 HPB : the official journal of the International Hepato Pancreato Biliary Association

12. Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: A systematic review and meta-analysis. (Full text)

Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: A systematic review and meta-analysis. This study aims at evaluating the benefits and harms of hepatitis B immune globulin (HBIG) and hepatitis B vaccine (HBVac) in preventing mother to child transmission in HBV surface antigen (HBsAg) positive pregnant women during antenatal period.Seven electronic databases

2020 Medicine PubMed abstract

13. Cost-effectiveness of Universal Hepatitis C Screening in Pregnant Women: A Systematic Review. (Abstract)

Cost-effectiveness of Universal Hepatitis C Screening in Pregnant Women: A Systematic Review. Hepatitis C virus (HCV) epidemiology has shifted from the baby-boomer generation to young women of childbearing age. The health benefits and cost-effectiveness (CE) of screening pregnant women remain controversial.To systematically review published studies evaluating the CE of screening pregnant women for HCV in the era of direct-acting antivirals (DAAs).We conducted a systematic literature search

2020 Journal of clinical gastroenterology

14. Hepatitis C Virus in Pregnancy: A Systematic Review of the Literature. (Abstract)

Hepatitis C Virus in Pregnancy: A Systematic Review of the Literature.  The aim of this study was to systematically review the literature to summarize recent demographic characteristics of hepatitis C virus (HCV) infection during pregnancy and the efficacy of risk-based versus universal screening. PubMed, EMBASE, and Cochrane Library were searched to identify relevant studies. Studies that recognized hepatitis C as a primary or secondary outcome, with pregnant women as the population

2020 American journal of perinatology

15. Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. (Abstract)

Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. 31880018 2020 04 22 2020 04 22 1365-2036 51 2 2020 01 Alimentary pharmacology & therapeutics Aliment. Pharmacol. Ther. Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. 309-310 10.1111/apt.15590 An Ran R Department of Hematology, Ruijin Hospital North, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Li Jiaming J Department (...) Aliment Pharmacol Ther. 2020 Jan;51(2):310-311 31880017 B-Lymphocytes Cohort Studies Hepatitis B Hepatitis B virus Hepatitis B, Chronic Humans Lymphoma, Non-Hodgkin Multiple Myeloma 2019 12 28 6 0 2019 12 28 6 0 2020 4 23 6 0 ppublish 31880018 10.1111/apt.15590

2020 Alimentary Pharmacology & Therapeutics

16. Medical waste handling and hepatitis B virus infection: A meta-analysis. (Abstract)

Medical waste handling and hepatitis B virus infection: A meta-analysis. Hepatitis B virus (HBV) infection is a significant occupational hazard in health care settings and represents a public health concern. The aim of this study was to investigate the association between medical waste handling and HBV infection by conducting a meta-analysis of available evidence.Pooled odds ratios (ORs) and confidence intervals (CIs) of the included studies were calculated, using the random-effects model

2020 American journal of infection control

17. Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. Authors' reply. (Full text)

Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. Authors' reply. 31880017 2020 04 22 2020 04 22 1365-2036 51 2 2020 01 Alimentary pharmacology & therapeutics Aliment. Pharmacol. Ther. Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. Authors' reply. 310-311 10.1111/apt.15607 Su Tung-Hung TH Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University (...) Hospital, Taipei, Taiwan. Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Chen Chi-Ling CL 0000-0002-9696-073X Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Kao Jia-Horng JH 0000-0002-2442-7952 Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan. Graduate

2020 Alimentary Pharmacology & Therapeutics PubMed abstract

18. A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection. (Full text)

A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection. Hepatitis E virus (HEV) is a non-enveloped, positive-sense, single-stranded RNA icosahedral virus belongs to the genus Orthohepevirus within the Hepeviridae family. HEV infection can be asymptomatic, or it can cause icteric or fulminant hepatitis. Off late, there have been a number of publications reporting the extra-hepatic manifestations of HEV infection, and this systematic review is aimed at summarizing (...) the available evidence in this regard. Two independent investigators searched PubMed, PubMed Central and Embase databases using the search string "(((hepatitis E) AND (Extrahepatic OR Extra-Hepatic))) OR ((Hepatitis E) AND (Neurology OR Cardiology OR Respiratory OR Lung OR Gastrointestinal OR musculoskeletal OR immunology OR pulmonary)) Filters: Abstract availability, English language, and Human studies". The extra-hepatic manifestations reported in each of the selected articles were classified and reported

2020 Medical sciences (Basel, Switzerland) PubMed abstract

19. Association between hepatitis B virus infection and risk of osteoporosis: a systematic review and meta-analysis: A protocol for systematic review. (Full text)

Association between hepatitis B virus infection and risk of osteoporosis: a systematic review and meta-analysis: A protocol for systematic review. The potential association between hepatitis B virus (HBV) infection and development of osteoporosis has drawn significant attention from clinicians and researchers in recent years due to the increasing prevalence of HBV infection. This study aims to perform a systematic review and meta-analysis of the literature to show whether HBV infection

2020 Medicine PubMed abstract

20. Seroprevalence and factors associated with hepatitis B virus infection in blood donors in Ethiopia: a systematic review and meta-analysis. (Abstract)

Seroprevalence and factors associated with hepatitis B virus infection in blood donors in Ethiopia: a systematic review and meta-analysis. Hepatitis B virus (HBV) can be transmitted during blood donation. This study estimated the pooled prevalence of hepatitis B and associated risk factors in blood donors in Ethiopia. The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. PubMed, African Journals Online (AJOL), the Excerpta Medica database (EMBASE (...) ), SCOPUS, Web of Science, Google Scholar, and JSTOR were accessed. Articles were searched from the Addis Ababa University research repository. The core search terms and phrases were "Hepatitis", "Hepatitis B", "Blood Donation", "Blood Donor", "Transfusion", "Transfusion Transmissible Infections", "Ethiopia", "Addis Ababa", "Adama", "Bahirdar", "Dire Dawa", "Gondar", "Mekelle", "Hawassa". The data were analyzed based on a DerSimonian-Laird random-effects model using STATA 14 and Review Manager version

2020 Archives of Virology